Article Details

Peptide CDMO market expands with a CAGR of 14.5% during 2023-2029 - openPR.com

Retrieved on: 2024-05-06 13:09:16

Tags for this article:

Click the tags to see associated articles and topics

Peptide CDMO market expands with a CAGR of 14.5% during 2023-2029 - openPR.com. View article details on hiswai:

Summary

The article discusses the rapid growth of the Peptide CDMO (Contract Development and Manufacturing Organization) market, forecasting a significant rise by 2029, driven by demand for peptide-based therapeutics and biotechnology advancements. CPC Scientific is mentioned among key players in market segmentation analysis.

Article found on: www.openpr.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up